USPTO serial 98021060
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $250
Asklepios BioPharmaceutical, Inc.
Research Triangle Park, NC, US
Durham, NC, US
DURHAM, NC, US
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kristen Mollnow Walsh
Kristen Mollnow Walsh Nixon Peabody LLP211 High Point Drive, Suite 110Victor, NY 14564-1061United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Enzymes, DNA vectors, viral vectors, rAAV vectors, and DNA extracts for the preparation of nucleic acid, for scientific and research purposes; enzymes for use in the preparation and creation of DNA extracts and DNA cassettes for scientific and industrial purposes; DNA vectors, viral vectors, rAAV vectors, and DNA extracts and DNA cassettes for scientific and research use; DNA vectors, viral vectors, rAAV vectors, DNA extracts for scientific and research purposes in the fields of agri-biotechnology and nanotechnology; Biological and biochemical reagents being DNA plasmid vectors, DNA vectors, and rAAV vectors, viral vectors that form a gene analysis system not for medical purposes; diagnostic reagents for scientific or research purposes, namely, a diagnostic kit consisting primarily of DNA vectors, rAAV vectors, and DNA plasmid vectors for scientific and research purposes | ACTIVE | — |
| 005 | Biotechnological products, namely, viral DNA vectors, DNA vectors, and rAAV vectors, for the delivery of genes and other materials, in the nature of DNA, RNA, and transcriptional targeting promoters, to a biological cell for medical purposes; biological preparations, namely, viral vectors, rAAV vectors, and DNA extracts for production of DNA vectors and viral vectors, for medical purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 13, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 23, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 22, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 20, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 19, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 6, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 6, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 10, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 9, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 2, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 1, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 28, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 28, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 24, 2025 | NOAC | CORRECTED NOA E-MAILED | — |
| Apr 24, 2025 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Apr 18, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 10, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 5, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Nov 5, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 29, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 14, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 31, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 17, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 17, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 8, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 8, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 8, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 7, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 7, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 9, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 2, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2023 | NWAP | NEW APPLICATION ENTERED | — |